Riding Towards Hope: NMDP Cycle’s Nationwide Mission
A Journey of Compassion and Challenge On March 30, the NMDP Cycle, previously known as the Be The Match® Tour de TC, embarks on a transformative six-ride tour across the United States. This inspiring event is not just a test of endurance and strength but a beacon of hope for those awaiting life-saving blood stem […]
Groundbreaking Discovery: Iowa State Researchers Revolutionize Blood Stem Cell Production
In an era where scientific breakthroughs are increasingly becoming the bedrock of medical advancements, a team of researchers at Iowa State University has made a monumental discovery that could potentially transform the landscape of regenerative medicine. As reported by Teodora Mitov, their pioneering research has uncovered a possible method to create blood stem cells in […]
Stem Cell Therapy for Lymphoma Treatment
Discover how stem cell therapy as a treatment for lymphoma can offer hope and advanced healing options for patients. Explore the transformative approach.
Celularity Revolutionizing Cancer Treatment: The Breakthrough of Stem Cell Therapy
A New Era in Oncology In an exciting development for the field of oncology, Celularity Inc., a leading biotechnology company, is set to present compelling in vivo data at the AACR Annual Meeting 2024. This data showcases the significant impact of their groundbreaking stem cell therapy, PT-CD16, in reducing cancer tumors. Derived from human placental […]
Explore the Benefits of Stem Cell Therapy in Cancer Immunotherapy
Discover how stem cell therapy enhances cancer immunotherapy, offering hope and new treatment avenues for patients.
Stem Cell-Based Therapies for Lymphoma
Understanding Lymphoma and the Promise of Stem Cell Therapy Lymphoma, a type of blood cancer that affects the lymphatic system, presents a significant health challenge worldwide. It’s a complex disease with various subtypes, each requiring a unique approach to treatment. In recent years, stem cell therapy has emerged as a beacon of hope for many […]
Hematopoietic Stem Cell Transplantation (HSCT) for Leukemia: A Modern Lifeline
When faced with leukemia, a type of cancer that launches a stealthy and devastating attack on the body’s blood-forming tissues, patients and their families often feel as though they’ve been cast adrift in a tempestuous sea. However, amidst these turbulent waters, Hematopoietic Stem Cell Transplantation (HSCT) emerges as a life-saving beacon of hope, offering a […]
IN8bio Announces Major Advancements in Leukemia and Glioblastoma Treatments
On October 12, 2023, IN8bio, a pioneering clinical-stage biopharmaceutical company, made a significant announcement regarding its gamma-delta T cell therapies. The company has successfully completed the enrollment for its Phase 1 study of INB-100, a potential treatment for leukemia patients. This marks a significant step forward as INB-100 is being evaluated for its safety when […]
Coeptis Therapeutics Expands Collaboration with University of Pittsburgh on CAR NK Cell Therapy
Biotech startup Coeptis Therapeutics announced an expanded partnership with the University of Pittsburgh today, licensing additional CAR NK cell therapy technology developed at Pitt. This new agreement builds on their existing collaboration around a CD19-targeting CAR NK cell therapy for blood cancers. The new technology, known as SNAP CAR NK cells, allows for more precise […]
Factors to Consider When Selecting Mismatched Unrelated Donors for Stem Cell Transplantation
In a recent interview at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX, Dr. Rohtesh Mehta from the Fred Hutchinson Cancer Research Center in Seattle, WA, discussed the crucial factors to consider when selecting mismatched unrelated donors (MMUDs) for stem cell transplantation (SCT). Historically, there were limited […]